VEGFA and neoplasm: Similarly to ET-1, Ang II is a mitogenic and pro-angiogenic vasoconstrictor that promotes tumour angiogenesis and inflammation through the upregulation of vascular endothelial growth factor (VEGF) and prostaglandins [201].